📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases. (2023)

First Author: Zheng B

Attributed to: COVID-19 Longitudinal Health and Wellbeing - National Core Study (LWH-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ckj/sfad184

PubMed Identifier: 37915915

Publication URI: http://europepmc.org/abstract/MED/37915915

Type: Journal Article/Review

Volume: 16

Parent Publication: Clinical kidney journal

Issue: 11

ISSN: 2048-8505